BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang L, Jian Y, Zhang ZY, Qi BW, Li YB, Long P, Yang Y, Wang X, Huang S, Huang J, Zhou LF, Ma J, Jiang CQ, Hu YH, Xiao WJ. Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes. World J Diabetes 2023; 14(7): 1057-1076 [PMID: 37547579 DOI: 10.4239/wjd.v14.i7.1057]
URL: https://www.wjgnet.com/1948-9358/full/v14/i7/1057.htm
Number Citing Articles
1
Chang-xing Liu, Xin-yi Guo, Ya-bin Zhou, He Wang. Therapeutic Role of Chinese Medicine Targeting Nrf2/HO-1 Signaling Pathway in Myocardial Ischemia/Reperfusion InjuryChinese Journal of Integrative Medicine 2024; 30(10): 949 doi: 10.1007/s11655-024-3657-0
2
Weisong Wang, Zengyu Zhang, Rongzhen Liu, Yu Zheng, Yaqi Hu, Xia Li, Zihao Shen, Hengyou Yuan, Jianhe Liu. Exploration of the Potential Bioactive Compounds and Functional Mechanism of Chaihu Sanshen Capsule in Ameliorating Myocardial Ischaemia–Reperfusion Injury: A Serum Pharmaco‐Chemistry With Network Pharmacology AnalysisJournal of Cellular and Molecular Medicine 2025; 29(14) doi: 10.1111/jcmm.70666
3
Qingfeng Gao, Chao Li, Peiqi Zhong, Yunqiang Yu, Zhurong Luo, Hao Chen. GDF15 restrains myocardial ischemia-reperfusion injury through inhibiting GPX4 mediated ferroptosisAging 2024;  doi: 10.18632/aging.205402